This inventor holds 172 USPTO granted patents and 31 published patent applications, plus 8 CIPO patents and 6 EPO patents, primarily in Medical Devices (CPC class A61B17-07207). Top assignees: Cardica, Inc., Ethicon Endo-Surgery, Inc., Beta Bionics, Inc.. Active years: 1995-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Cincinnati, OH (US) (1995 - 2002)
- Flaggstaff, AZ (US) (2023)
- Flagstaff, AZ (US) (1999 - 2024)
Company Filing History:
78 out of 166 
36 out of 2,216 
19 out of 57 
Years Active: 1995-2025
Areas of Expertise:
Title: Bryan Dale Knodel: Innovator in Blood Glucose Control Systems
Introduction:
In the world of medical technology, innovators like Bryan Dale Knodel play a crucial role in designing groundbreaking solutions to improve patient care. Knodel, based in Flagstaff, Arizona, has made significant contributions to the field, particularly in the area of switching blood glucose control systems without interrupting therapy delivery. With an impressive number of 139 patents to his name, Knodel continues to pioneer advancements that benefit patients.
Latest Patents:
Among Bryan Dale Knodel's notable patents is the "Switching blood glucose control system execution without interruption of therapy delivery." This patent introduces a system that allows the seamless transition of control between different versions of an application executing on an ambulatory medical device. This ensures uninterrupted therapy for patients undergoing treatment. Additionally, Knodel's patent on "Blood glucose control system switching without interruption of therapy delivery" demonstrates his commitment to optimizing ambulatory medical devices to enhance patient care.
Career Highlights:
Throughout his career, Bryan Dale Knodel has worked for renowned companies, including Cardica, Inc. and Ethicon GmbH. These organizations have provided Knodel with opportunities to collaborate with industry experts and develop innovative solutions. His expertise in medical technology and passion for improving patient outcomes have contributed to his impressive patent record.
Collaborations:
Bryan Dale Knodel has had the privilege of collaborating with accomplished professionals in his field. Notably, his collaborations include working with esteemed individuals such as Philipe Roget Manoux and Bernard A. Hausen. These collaborations have enabled Knodel to exchange ideas, refine his innovations, and further advance the field of blood glucose control systems.
Conclusion:
Bryan Dale Knodel's contributions to the field of medical technology, particularly in the realm of blood glucose control systems, have had a significant impact on patient care. His patents highlight his ingenuity in creating solutions that allow seamless switching between applications without interrupting therapy delivery. Through collaborations with industry leaders and his extensive career experience, Knodel continues to push the boundaries of medical innovation. As we eagerly anticipate his future endeavors, it is certain that Bryan Dale Knodel will remain a prominent force in the advancement of medical technologies for years to come.
(Note: The information provided in this article is fictional and solely created for the purpose of the task at hand.)
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile